Fabrizio Remotti, MD

Expertise in: 
Board Certifications: 
Accepting New Patients
Profile Headshot


Areas of Expertise / Conditions Treated

Sarcoma, Soft Tissue Sarcoma, Bone Diseases, Bone Disease, Bone Cancer, Bone and Soft Tissue Tumors, Bone and Soft Tissue Sarcoma, Bone and Soft Tissue Abnormalities, Bone and Joint Infections, Soft Tissue Mass, Immunohistochemistry

Academic Appointments

  • Assistant Professor of Pathology & Cell Biology at CUMC

Administrative Titles

  • Assistant Professor of Pathology & Cell Biology at CUMC

Hospital Affiliations

  • NewYork-Presbyterian/Columbia


  • Italian


  • Male

Insurance Accepted


  • EPO
  • HMO
  • Medicare Managed Care
  • NY Signature
  • POS
  • PPO
  • Signature Administrators
  • Student Health


  • EPO
  • Great West
  • HMO
  • POS
  • PPO


  • HMO
  • Medicare Managed Care
  • PPO


  • ConnectiCare
  • EPO
  • Essential Plan
  • HMO
  • Medicaid Managed Care
  • Medicare Managed Care
  • POS
  • PPO
  • Select Care (Exchange)
  • Vytra

Empire Blue Cross Blue Shield

  • Blue Priority
  • EPO
  • HMO
  • Medicare (Mediblue)
  • NYP Employee Plan
  • Pathway (Exchange)
  • POS
  • PPO

Local 1199

  • Local 1199


  • MagnaCare


  • Multiplan

Oxford Health Plans

  • Freedom
  • Liberty
  • Medicare Managed Care




  • Columbia University Employee Plan
  • Compass (Exchange)
  • EPO
  • Essential Plan
  • HMO
  • Medicaid (Community Plan)
  • Medicare Managed Care
  • POS
  • PPO

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Credentials & Experience

Education & Training

  • University of Rome
  • Residency: University of Southern California Medical Center
  • Fellowship: Armed Forces Institute

Board Certifications

  • Pathology-Anatomic/Pathology-Clinical




Jan 1 2014 - Jun 30 2015

Selected Publications

Zhang X, Cruz FD, Terry M, Remotti F, Matushansky I. Terminal differentiation and loss of tumorigenicity of human cancers via pluripotency-based reprogramming. Oncogene. 2013;32(18):2249-60, 60 e1-21.

Remotti F, Feldman F. Nonneoplastic lesions that simulate primary tumors of bone. Archives of pathology & laboratory medicine. 2012;136(7):772-88.

Charytonowicz E, Terry M, Coakley K, Telis L, Remotti F, Cordon-Cardo C, Taub RN, Matushansky I. PPARgamma agonists enhance ET-743-induced adipogenic differentiation in a transgenic mouse model of myxoid round cell liposarcoma. The Journal of clinical investigation. 2012;122(3):886-98.

Gonzalez-Lomas G, Cassilly RT, Remotti F, Levine WN. Is the etiology of pretibial cyst formation after absorbable interference screw use related to a foreign body reaction? Clinical orthopaedics and related research. 2011;469(4):1082-8.

Singh B, Mense SM, Bhat NK, Putty S, Guthiel WA, Remotti F, Bhat HK. Dietary quercetin exacerbates the development of estrogen-induced breast tumors in female ACI rats. Toxicology and applied pharmacology. 2010;247(2):83-90.

Singh B, Mense SM, Remotti F, Liu X, Bhat HK. Antioxidant butylated hydroxyanisole inhibits estrogen-induced breast carcinogenesis in female ACI rats. Journal of biochemical and molecular toxicology. 2009;23(3):202-11.

Mills J, Matos T, Charytonowicz E, Hricik T, Castillo-Martin M, Remotti F, Lee FY, Matushansky I. Characterization and comparison of the properties of sarcoma cell lines in vitro and in vivo. Human cell. 2009;22(4):85-93.

Mense SM, Singh B, Remotti F, Liu X, Bhat HK. Vitamin C and alpha-naphthoflavone prevent estrogen-induced mammary tumors and decrease oxidative stress in female ACI rats. Carcinogenesis. 2009;30(7):1202-8.

Mense SM, Remotti F, Bhan A, Singh B, El-Tamer M, Hei TK, Bhat HK. Estrogen-induced breast cancer: alterations in breast morphology and oxidative stress as a function of estrogen exposure. Toxicology and applied pharmacology. 2008;232(1):78-85.

Saqi A, Giorgadze TA, Eleazar J, Remotti F, Vazquez MF. Clear cell and eosinophilic oncocytomas of salivary gland: cytological variants or parallels? Diagnostic cytopathology. 2007;35(3):158-63.

Saqi A, Alexis D, Remotti F, Bhagat G. Usefulness of CDX2 and TTF-1 in differentiating gastrointestinal from pulmonary carcinoids. American journal of clinical pathology. 2005;123(3):394-404.

Fetsch JF, Laskin WB, Michal M, Remotti F, Heffner D, Ellis G, Furlong M, Miettinen M. Ectopic hamartomatous thymoma: a clinicopathologic and immunohistochemical analysis of 21 cases with data supporting reclassification as a branchial anlage mixed tumor. The American journal of surgical pathology. 2004;28(10):1360-70.

Fetsch JF, Vinh TN, Remotti F, Walker EA, Murphey MD, Sweet DE. Tenosynovial (extraarticular) chondromatosis: an analysis of 37 cases of an underrecognized clinicopathologic entity with a strong predilection for the hands and feet and a high local recurrence rate. The American journal of surgical pathology. 2003;27(9):1260-8.

Remotti F, Fetsch JF, Miettinen M. Keratin 1 expression in endothelia and mesenchymal tumors: an immunohistochemical analysis of normal and neoplastic tissues. Human pathology. 2001;32(8):873-9.

Lemos MM, Kindblom LG, Meis-Kindblom JM, Remotti F, Ryd W, Gunterberg B, Willen H. Fine-needle aspiration characteristics of hibernoma. Cancer. 2001;93(3):206-10.

Bergh P, Kindblom LG, Gunterberg B, Remotti F, Ryd W, Meis-Kindblom JM. Prognostic factors in chordoma of the sacrum and mobile spine: a study of 39 patients. Cancer. 2000;88(9):2122-34.

Cochran AJ, Binder S, Remotti F. The role of microscopic evaluation in the management of cutaneous melanoma. Cancer treatment and research. 1993;65:69-102.